

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | homocysteine metabolic process (GO:0050667) | 7.81420320 |
| 2 | postsynaptic membrane organization (GO:0001941) | 6.76004906 |
| 3 | microtubule nucleation (GO:0007020) | 6.12319079 |
| 4 | regulation of plasminogen activation (GO:0010755) | 6.06824489 |
| 5 | regulation of synapse structural plasticity (GO:0051823) | 5.85832974 |
| 6 | folic acid-containing compound biosynthetic process (GO:0009396) | 5.73172207 |
| 7 | cysteine metabolic process (GO:0006534) | 5.72365553 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 5.70237078 |
| 9 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 5.57857851 |
| 10 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 5.54439961 |
| 11 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 5.54439961 |
| 12 | synaptic vesicle maturation (GO:0016188) | 5.54180456 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.47244422 |
| 14 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.41915343 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.40154923 |
| 16 | response to pheromone (GO:0019236) | 5.27096967 |
| 17 | prepulse inhibition (GO:0060134) | 5.23786021 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.18980979 |
| 19 | auditory behavior (GO:0031223) | 5.11632509 |
| 20 | vocalization behavior (GO:0071625) | 5.00801102 |
| 21 | locomotory exploration behavior (GO:0035641) | 4.99265096 |
| 22 | adenosine metabolic process (GO:0046085) | 4.98390603 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.85899954 |
| 24 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.78322469 |
| 25 | striatum development (GO:0021756) | 4.73022911 |
| 26 | synaptic transmission, dopaminergic (GO:0001963) | 4.72498455 |
| 27 | white fat cell differentiation (GO:0050872) | 4.66508802 |
| 28 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.66098329 |
| 29 | protein localization to synapse (GO:0035418) | 4.65104619 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 4.64842890 |
| 31 | response to auditory stimulus (GO:0010996) | 4.58394599 |
| 32 | cochlea development (GO:0090102) | 4.55309810 |
| 33 | negative regulation of DNA biosynthetic process (GO:2000279) | 4.55009677 |
| 34 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.53811280 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 4.50301582 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 4.48869062 |
| 37 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.47856245 |
| 38 | eye photoreceptor cell differentiation (GO:0001754) | 4.46752331 |
| 39 | photoreceptor cell differentiation (GO:0046530) | 4.46752331 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.43711627 |
| 41 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.40320903 |
| 42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.37903897 |
| 43 | negative regulation of catenin import into nucleus (GO:0035414) | 4.36836890 |
| 44 | primary amino compound metabolic process (GO:1901160) | 4.36208711 |
| 45 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.36015741 |
| 46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.33976124 |
| 47 | innervation (GO:0060384) | 4.33453965 |
| 48 | dopamine receptor signaling pathway (GO:0007212) | 4.31440493 |
| 49 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.30594138 |
| 50 | purine nucleotide salvage (GO:0032261) | 4.27784315 |
| 51 | presynaptic membrane assembly (GO:0097105) | 4.21073882 |
| 52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.19822756 |
| 53 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.18527567 |
| 54 | behavioral response to nicotine (GO:0035095) | 4.05187849 |
| 55 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.00596447 |
| 56 | neurotransmitter secretion (GO:0007269) | 3.96358983 |
| 57 | protein-chromophore linkage (GO:0018298) | 3.96111324 |
| 58 | inner ear receptor cell development (GO:0060119) | 3.92889711 |
| 59 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.91242106 |
| 60 | neuron cell-cell adhesion (GO:0007158) | 3.88822368 |
| 61 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.88700409 |
| 62 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.86207993 |
| 63 | histone H4-K12 acetylation (GO:0043983) | 3.85809043 |
| 64 | presynaptic membrane organization (GO:0097090) | 3.83657875 |
| 65 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.82733351 |
| 66 | negative regulation of Ras GTPase activity (GO:0034261) | 3.82522670 |
| 67 | exploration behavior (GO:0035640) | 3.81758816 |
| 68 | regulation of synaptic vesicle transport (GO:1902803) | 3.81352360 |
| 69 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.78196537 |
| 70 | protein-cofactor linkage (GO:0018065) | 3.77367330 |
| 71 | L-serine metabolic process (GO:0006563) | 3.77075612 |
| 72 | neuron-neuron synaptic transmission (GO:0007270) | 3.75827832 |
| 73 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.68427735 |
| 74 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.68427735 |
| 75 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.68141484 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.67994409 |
| 77 | glutamate secretion (GO:0014047) | 3.66561067 |
| 78 | response to amphetamine (GO:0001975) | 3.63815034 |
| 79 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.62017451 |
| 80 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.62017451 |
| 81 | neuromuscular process controlling balance (GO:0050885) | 3.61626053 |
| 82 | synaptic transmission, glutamatergic (GO:0035249) | 3.61533002 |
| 83 | mechanosensory behavior (GO:0007638) | 3.60819193 |
| 84 | membrane hyperpolarization (GO:0060081) | 3.60020482 |
| 85 | behavioral response to cocaine (GO:0048148) | 3.59358224 |
| 86 | long-term memory (GO:0007616) | 3.59135861 |
| 87 | positive regulation of neurotransmitter transport (GO:0051590) | 3.58117148 |
| 88 | visual learning (GO:0008542) | 3.55565673 |
| 89 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.55420882 |
| 90 | glutamate receptor signaling pathway (GO:0007215) | 3.53187883 |
| 91 | positive regulation of membrane potential (GO:0045838) | 3.52573770 |
| 92 | mitochondrial RNA metabolic process (GO:0000959) | 3.52522944 |
| 93 | positive regulation of synapse maturation (GO:0090129) | 3.52456214 |
| 94 | mating behavior (GO:0007617) | 3.51091107 |
| 95 | axon ensheathment in central nervous system (GO:0032291) | 3.48280679 |
| 96 | central nervous system myelination (GO:0022010) | 3.48280679 |
| 97 | behavioral defense response (GO:0002209) | 3.45826235 |
| 98 | behavioral fear response (GO:0001662) | 3.45826235 |
| 99 | neuronal ion channel clustering (GO:0045161) | 3.45440870 |
| 100 | transmission of nerve impulse (GO:0019226) | 3.45345467 |
| 101 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.45305905 |
| 102 | cellular potassium ion homeostasis (GO:0030007) | 3.45052325 |
| 103 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.44775812 |
| 104 | neuron recognition (GO:0008038) | 3.42251500 |
| 105 | establishment of mitochondrion localization (GO:0051654) | 3.41607901 |
| 106 | regulation of postsynaptic membrane potential (GO:0060078) | 3.40381163 |
| 107 | desmosome organization (GO:0002934) | 3.40304870 |
| 108 | sodium ion export (GO:0071436) | 3.40108073 |
| 109 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.39457108 |
| 110 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.39390421 |
| 111 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.38797085 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.37976811 |
| 113 | axonal fasciculation (GO:0007413) | 3.37904866 |
| 114 | regulation of female receptivity (GO:0045924) | 3.36434897 |
| 115 | cell migration involved in heart development (GO:0060973) | 3.33857322 |
| 116 | visual behavior (GO:0007632) | 3.31819973 |
| 117 | adenosine receptor signaling pathway (GO:0001973) | 3.31038880 |
| 118 | rRNA methylation (GO:0031167) | 3.30494324 |
| 119 | learning (GO:0007612) | 3.27483073 |
| 120 | dermatan sulfate biosynthetic process (GO:0030208) | 3.27383288 |
| 121 | regulation of gonadotropin secretion (GO:0032276) | 3.27005536 |
| 122 | positive regulation of dendritic spine development (GO:0060999) | 3.26850188 |
| 123 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.26254967 |
| 124 | acrosome assembly (GO:0001675) | 3.26217366 |
| 125 | dendrite morphogenesis (GO:0048813) | 3.25670577 |
| 126 | regulation of synaptic plasticity (GO:0048167) | 3.25249535 |
| 127 | regulation of endothelial cell differentiation (GO:0045601) | 3.23045083 |
| 128 | regulation of sequestering of triglyceride (GO:0010889) | 3.22685584 |
| 129 | cartilage morphogenesis (GO:0060536) | 3.22219429 |
| 130 | cell migration in hindbrain (GO:0021535) | 3.17955483 |
| 131 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.17021623 |
| 132 | gamma-aminobutyric acid transport (GO:0015812) | 3.14604488 |
| 133 | regulation of neurotransmitter uptake (GO:0051580) | 3.14267096 |
| 134 | synaptic vesicle endocytosis (GO:0048488) | 3.13183369 |
| 135 | serine family amino acid biosynthetic process (GO:0009070) | 3.11252809 |
| 136 | neuronal action potential propagation (GO:0019227) | 3.10576015 |
| 137 | regulation of catecholamine metabolic process (GO:0042069) | 3.09716839 |
| 138 | regulation of dopamine metabolic process (GO:0042053) | 3.09716839 |
| 139 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.09421010 |
| 140 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.08416824 |
| 141 | activation of protein kinase A activity (GO:0034199) | 3.07219337 |
| 142 | neurotransmitter transport (GO:0006836) | 3.07170361 |
| 143 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.05937493 |
| 144 | sulfur amino acid biosynthetic process (GO:0000097) | 3.05739790 |
| 145 | membrane depolarization during action potential (GO:0086010) | 3.04040751 |
| 146 | membrane depolarization (GO:0051899) | 3.03445541 |
| 147 | regulation of dendritic spine development (GO:0060998) | 3.03373154 |
| 148 | regulation of glutamate secretion (GO:0014048) | 3.03032227 |
| 149 | fear response (GO:0042596) | 3.02134836 |
| 150 | regulation of neurotransmitter transport (GO:0051588) | 3.01935585 |
| 151 | cell communication by electrical coupling (GO:0010644) | 3.01351017 |
| 152 | cAMP catabolic process (GO:0006198) | 3.00946770 |
| 153 | negative regulation of telomerase activity (GO:0051974) | 2.99142648 |
| 154 | organic cation transport (GO:0015695) | 2.98116669 |
| 155 | response to lipoprotein particle (GO:0055094) | 2.93016715 |
| 156 | tetrahydrofolate metabolic process (GO:0046653) | 2.90913779 |
| 157 | dermatan sulfate metabolic process (GO:0030205) | 2.89272503 |
| 158 | adult feeding behavior (GO:0008343) | 2.86736762 |
| 159 | galactose catabolic process (GO:0019388) | 2.85328713 |
| 160 | galactose metabolic process (GO:0006012) | 2.82434851 |
| 161 | G-protein coupled receptor internalization (GO:0002031) | 2.82164400 |
| 162 | serine family amino acid catabolic process (GO:0009071) | 2.81971385 |
| 163 | folic acid-containing compound metabolic process (GO:0006760) | 2.75059814 |
| 164 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.71664439 |
| 165 | tRNA modification (GO:0006400) | 2.69810744 |
| 166 | nucleobase catabolic process (GO:0046113) | 2.67853662 |
| 167 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.67221173 |
| 168 | rRNA modification (GO:0000154) | 2.66966643 |
| 169 | nucleoside transmembrane transport (GO:1901642) | 2.66410729 |
| 170 | growth hormone secretion (GO:0030252) | 2.66410024 |
| 171 | platelet dense granule organization (GO:0060155) | 2.65872182 |
| 172 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.61700334 |
| 173 | adaptation of signaling pathway (GO:0023058) | 2.59665215 |
| 174 | negative regulation of astrocyte differentiation (GO:0048712) | 2.57775039 |
| 175 | regulation of neuron projection regeneration (GO:0070570) | 2.51670596 |
| 176 | regulation of axon regeneration (GO:0048679) | 2.51670596 |
| 177 | neural crest cell development (GO:0014032) | 2.48589078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 7.84076490 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.83635397 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.34167766 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14403483 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11922863 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09620713 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01706669 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.95492786 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.86253077 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.83580071 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.83580071 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.83399642 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.72166982 |
| 14 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.65907448 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.65808955 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.64939091 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.62043706 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.59101499 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.55339086 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55307864 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50127717 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46521565 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.46482724 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44590652 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.41702135 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.38638573 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.35430141 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.26634831 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17558744 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99658178 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.96587903 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94362343 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88487681 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.74957717 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.65307636 |
| 36 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.61622523 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61133818 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.58952890 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.53123439 |
| 40 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.47943058 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46656238 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45170745 |
| 43 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.43417608 |
| 44 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.41620777 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41383330 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40094373 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39078736 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36367988 |
| 49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34797801 |
| 50 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34310251 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33051830 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29611403 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25372965 |
| 54 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.25272821 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24698091 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23210816 |
| 57 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23136849 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21683306 |
| 59 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21551245 |
| 60 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.21285846 |
| 61 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21122603 |
| 62 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21094495 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20621070 |
| 64 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19906899 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.19826774 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19272761 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18561939 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17512847 |
| 69 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16896109 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16491010 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16139134 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15099217 |
| 73 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14935901 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14741834 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12429115 |
| 76 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10119634 |
| 77 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10052995 |
| 78 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.09243975 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09165813 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08015829 |
| 81 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07327738 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06917096 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05863212 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05025415 |
| 85 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03886193 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03090566 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02680624 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02281539 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01932241 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01695133 |
| 91 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.01326926 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00430931 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00430931 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99708133 |
| 95 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98955715 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98674110 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98474332 |
| 98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97940861 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97601452 |
| 100 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.97452373 |
| 101 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97053492 |
| 102 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96698340 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96312155 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95157753 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93911691 |
| 106 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93540224 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93472743 |
| 108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92703112 |
| 109 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91554145 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91106508 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 0.91071073 |
| 112 | EWS_26573619_Chip-Seq_HEK293_Human | 0.90930376 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90738600 |
| 114 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90396684 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90195589 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89711143 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89562544 |
| 118 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89512692 |
| 119 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88842043 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87794568 |
| 121 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87732528 |
| 122 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87540130 |
| 123 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87227313 |
| 124 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86697177 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86373500 |
| 126 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85483150 |
| 127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.83066106 |
| 128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82424222 |
| 129 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81185153 |
| 130 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80921737 |
| 131 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80855447 |
| 132 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.79876273 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79390249 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79077991 |
| 135 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.78135238 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76367714 |
| 137 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.75787349 |
| 138 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75786316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 6.07774829 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.99341401 |
| 3 | MP0003880_abnormal_central_pattern | 3.90419928 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.89841369 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.45203513 |
| 6 | MP0005670_abnormal_white_adipose | 3.29438561 |
| 7 | MP0009745_abnormal_behavioral_response | 3.16862931 |
| 8 | MP0004270_analgesia | 3.07019622 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.06228036 |
| 10 | MP0004147_increased_porphyrin_level | 3.00437275 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.94896776 |
| 12 | MP0001529_abnormal_vocalization | 2.87905247 |
| 13 | MP0002064_seizures | 2.75804075 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.62317794 |
| 15 | MP0001486_abnormal_startle_reflex | 2.60847918 |
| 16 | MP0009046_muscle_twitch | 2.44055795 |
| 17 | MP0001984_abnormal_olfaction | 2.35408541 |
| 18 | MP0002272_abnormal_nervous_system | 2.21342943 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.21114141 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.20654514 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.20430300 |
| 22 | MP0005360_urolithiasis | 2.16445654 |
| 23 | MP0005646_abnormal_pituitary_gland | 2.12745766 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.10411167 |
| 25 | MP0000778_abnormal_nervous_system | 2.04746716 |
| 26 | MP0002938_white_spotting | 1.96377616 |
| 27 | MP0003122_maternal_imprinting | 1.93556518 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.90575660 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.87151862 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.83406529 |
| 31 | MP0001970_abnormal_pain_threshold | 1.81262700 |
| 32 | MP0002184_abnormal_innervation | 1.80140363 |
| 33 | MP0004924_abnormal_behavior | 1.79171291 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.79171291 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.78454523 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.77675271 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.75305107 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.73741099 |
| 39 | MP0003136_yellow_coat_color | 1.72652718 |
| 40 | MP0005171_absent_coat_pigmentation | 1.69552482 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.63587189 |
| 42 | MP0008569_lethality_at_weaning | 1.63355579 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.62511288 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.56681740 |
| 45 | MP0004043_abnormal_pH_regulation | 1.53828900 |
| 46 | MP0002095_abnormal_skin_pigmentation | 1.53262565 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.52642406 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.51968987 |
| 49 | MP0000955_abnormal_spinal_cord | 1.49588996 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.47903327 |
| 51 | MP0004133_heterotaxia | 1.47505507 |
| 52 | MP0002882_abnormal_neuron_morphology | 1.46875067 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.37405774 |
| 54 | MP0005367_renal/urinary_system_phenotyp | 1.37162188 |
| 55 | MP0000516_abnormal_urinary_system | 1.37162188 |
| 56 | MP0004885_abnormal_endolymph | 1.36614392 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.34596191 |
| 58 | MP0002090_abnormal_vision | 1.33264288 |
| 59 | MP0003879_abnormal_hair_cell | 1.31499854 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.29604437 |
| 61 | MP0002736_abnormal_nociception_after | 1.27184669 |
| 62 | MP0000631_abnormal_neuroendocrine_gland | 1.25893481 |
| 63 | MP0002735_abnormal_chemical_nociception | 1.25699510 |
| 64 | MP0001188_hyperpigmentation | 1.24271226 |
| 65 | MP0003329_amyloid_beta_deposits | 1.23579296 |
| 66 | MP0000026_abnormal_inner_ear | 1.23503228 |
| 67 | MP0004130_abnormal_muscle_cell | 1.16961232 |
| 68 | MP0004858_abnormal_nervous_system | 1.16772247 |
| 69 | MP0002152_abnormal_brain_morphology | 1.14842495 |
| 70 | MP0005394_taste/olfaction_phenotype | 1.13091089 |
| 71 | MP0005499_abnormal_olfactory_system | 1.13091089 |
| 72 | MP0010030_abnormal_orbit_morphology | 1.12470957 |
| 73 | MP0005409_darkened_coat_color | 1.12028274 |
| 74 | MP0002653_abnormal_ependyma_morphology | 1.11565115 |
| 75 | MP0001905_abnormal_dopamine_level | 1.09743472 |
| 76 | MP0003137_abnormal_impulse_conducting | 1.08279352 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 1.07166287 |
| 78 | MP0002069_abnormal_eating/drinking_beha | 1.02693604 |
| 79 | MP0005253_abnormal_eye_physiology | 1.02040471 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 1.01886767 |
| 81 | MP0001485_abnormal_pinna_reflex | 1.01739645 |
| 82 | MP0000647_abnormal_sebaceous_gland | 1.00868051 |
| 83 | MP0001177_atelectasis | 1.00332807 |
| 84 | MP0004142_abnormal_muscle_tone | 0.98809162 |
| 85 | MP0003633_abnormal_nervous_system | 0.98113114 |
| 86 | MP0004085_abnormal_heartbeat | 0.97386403 |
| 87 | MP0000751_myopathy | 0.96455921 |
| 88 | MP0005332_abnormal_amino_acid | 0.93938174 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.93176936 |
| 90 | MP0002229_neurodegeneration | 0.92913210 |
| 91 | MP0006292_abnormal_olfactory_placode | 0.87325284 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.87271023 |
| 93 | MP0008872_abnormal_physiological_respon | 0.85727021 |
| 94 | MP0003787_abnormal_imprinting | 0.84601890 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 0.83803053 |
| 96 | MP0003631_nervous_system_phenotype | 0.83079392 |
| 97 | MP0001764_abnormal_homeostasis | 0.82651369 |
| 98 | MP0003075_altered_response_to | 0.82001677 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.79306803 |
| 100 | MP0003698_abnormal_male_reproductive | 0.79251417 |
| 101 | MP0008995_early_reproductive_senescence | 0.78934467 |
| 102 | MP0003121_genomic_imprinting | 0.78450303 |
| 103 | MP0003283_abnormal_digestive_organ | 0.77442057 |
| 104 | MP0003634_abnormal_glial_cell | 0.77352804 |
| 105 | MP0004742_abnormal_vestibular_system | 0.76402580 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.75964595 |
| 107 | MP0000534_abnormal_ureter_morphology | 0.75667577 |
| 108 | MP0003942_abnormal_urinary_system | 0.75637561 |
| 109 | MP0008874_decreased_physiological_sensi | 0.75566882 |
| 110 | MP0004233_abnormal_muscle_weight | 0.75109993 |
| 111 | MP0000920_abnormal_myelination | 0.74997913 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.73516215 |
| 113 | MP0003861_abnormal_nervous_system | 0.71503833 |
| 114 | MP0001270_distended_abdomen | 0.68535230 |
| 115 | MP0002396_abnormal_hematopoietic_system | 0.67498309 |
| 116 | MP0005248_abnormal_Harderian_gland | 0.67352673 |
| 117 | MP0008775_abnormal_heart_ventricle | 0.67158690 |
| 118 | MP0001756_abnormal_urination | 0.65641574 |
| 119 | MP0005535_abnormal_body_temperature | 0.65502285 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.64838206 |
| 121 | MP0002210_abnormal_sex_determination | 0.64776475 |
| 122 | MP0001664_abnormal_digestion | 0.63540130 |
| 123 | MP0003690_abnormal_glial_cell | 0.60499257 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.59886654 |
| 125 | MP0005195_abnormal_posterior_eye | 0.59724576 |
| 126 | MP0001661_extended_life_span | 0.58985090 |
| 127 | MP0005410_abnormal_fertilization | 0.57296624 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.56893410 |
| 129 | MP0003632_abnormal_nervous_system | 0.56201557 |
| 130 | MP0001963_abnormal_hearing_physiology | 0.55914102 |
| 131 | MP0001943_abnormal_respiration | 0.55740864 |
| 132 | MP0002089_abnormal_postnatal_growth/wei | 0.55323299 |
| 133 | MP0002102_abnormal_ear_morphology | 0.54038355 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.53552951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 7.57083143 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 7.57083143 |
| 3 | Hyperalaninemia (HP:0003348) | 7.57083143 |
| 4 | Myokymia (HP:0002411) | 7.27693047 |
| 5 | Focal motor seizures (HP:0011153) | 6.02460985 |
| 6 | Congenital sensorineural hearing impairment (HP:0008527) | 5.97049198 |
| 7 | Constricted visual fields (HP:0001133) | 5.55462493 |
| 8 | Focal seizures (HP:0007359) | 5.02115417 |
| 9 | White forelock (HP:0002211) | 4.86822138 |
| 10 | Patchy hypopigmentation of hair (HP:0011365) | 4.32522066 |
| 11 | Birth length less than 3rd percentile (HP:0003561) | 4.29935911 |
| 12 | Homocystinuria (HP:0002156) | 4.28627283 |
| 13 | Abnormality of homocysteine metabolism (HP:0010919) | 4.28627283 |
| 14 | Esophageal varix (HP:0002040) | 4.27306830 |
| 15 | Ankle clonus (HP:0011448) | 4.21652796 |
| 16 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.17472310 |
| 17 | Epileptic encephalopathy (HP:0200134) | 4.04017946 |
| 18 | Poor eye contact (HP:0000817) | 3.82964683 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.80051843 |
| 20 | Visual hallucinations (HP:0002367) | 3.62624597 |
| 21 | Torticollis (HP:0000473) | 3.60421958 |
| 22 | Polyphagia (HP:0002591) | 3.59850978 |
| 23 | Congenital stationary night blindness (HP:0007642) | 3.58406826 |
| 24 | Attenuation of retinal blood vessels (HP:0007843) | 3.52876898 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.52680842 |
| 26 | Failure to thrive in infancy (HP:0001531) | 3.49680862 |
| 27 | Abnormal social behavior (HP:0012433) | 3.39986620 |
| 28 | Impaired social interactions (HP:0000735) | 3.39986620 |
| 29 | Febrile seizures (HP:0002373) | 3.38428008 |
| 30 | Broad-based gait (HP:0002136) | 3.36984301 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.34781269 |
| 32 | Depression (HP:0000716) | 3.32051242 |
| 33 | Absence seizures (HP:0002121) | 3.18294377 |
| 34 | Focal dystonia (HP:0004373) | 3.05125090 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 3.04758792 |
| 36 | Generalized tonic-clonic seizures (HP:0002069) | 3.04752028 |
| 37 | Heterochromia iridis (HP:0001100) | 3.04294755 |
| 38 | Anxiety (HP:0000739) | 3.04282663 |
| 39 | Agitation (HP:0000713) | 3.03511814 |
| 40 | Craniofacial dystonia (HP:0012179) | 3.03304161 |
| 41 | Urinary urgency (HP:0000012) | 3.01132686 |
| 42 | Action tremor (HP:0002345) | 2.97123538 |
| 43 | Central scotoma (HP:0000603) | 2.96366537 |
| 44 | Chronic hepatic failure (HP:0100626) | 2.95837258 |
| 45 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.95743878 |
| 46 | Single umbilical artery (HP:0001195) | 2.95743878 |
| 47 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.95743878 |
| 48 | Papilledema (HP:0001085) | 2.93195190 |
| 49 | Annular pancreas (HP:0001734) | 2.92046229 |
| 50 | Pointed chin (HP:0000307) | 2.91782129 |
| 51 | Progressive cerebellar ataxia (HP:0002073) | 2.90853382 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.89741961 |
| 53 | Abnormality of the lower motor neuron (HP:0002366) | 2.89228429 |
| 54 | Dialeptic seizures (HP:0011146) | 2.88861678 |
| 55 | Spastic gait (HP:0002064) | 2.86290402 |
| 56 | Hemiparesis (HP:0001269) | 2.85159115 |
| 57 | Dysdiadochokinesis (HP:0002075) | 2.83546731 |
| 58 | Truncal ataxia (HP:0002078) | 2.83052606 |
| 59 | Ankyloglossia (HP:0010296) | 2.81866918 |
| 60 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.79437295 |
| 61 | Mutism (HP:0002300) | 2.79077022 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.77933854 |
| 63 | Abnormal EKG (HP:0003115) | 2.75252208 |
| 64 | Abnormality of cochlea (HP:0000375) | 2.63477084 |
| 65 | Poor speech (HP:0002465) | 2.61645706 |
| 66 | Morphological abnormality of the inner ear (HP:0011390) | 2.60108240 |
| 67 | Excessive salivation (HP:0003781) | 2.59464805 |
| 68 | Drooling (HP:0002307) | 2.59464805 |
| 69 | Chorioretinal atrophy (HP:0000533) | 2.59031579 |
| 70 | Prolonged QT interval (HP:0001657) | 2.58810768 |
| 71 | Insomnia (HP:0100785) | 2.56792810 |
| 72 | Visceral angiomatosis (HP:0100761) | 2.55912728 |
| 73 | Pendular nystagmus (HP:0012043) | 2.54728735 |
| 74 | Stereotypic behavior (HP:0000733) | 2.53468585 |
| 75 | Clonus (HP:0002169) | 2.48253161 |
| 76 | Pigmentary retinal degeneration (HP:0001146) | 2.44246891 |
| 77 | Conjunctival telangiectasia (HP:0000524) | 2.43799836 |
| 78 | Obsessive-compulsive behavior (HP:0000722) | 2.43612839 |
| 79 | Lower limb muscle weakness (HP:0007340) | 2.42024702 |
| 80 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41661730 |
| 81 | Sleep apnea (HP:0010535) | 2.40720729 |
| 82 | Neoplasm of the heart (HP:0100544) | 2.39435113 |
| 83 | Amblyopia (HP:0000646) | 2.39420107 |
| 84 | Gaze-evoked nystagmus (HP:0000640) | 2.39412347 |
| 85 | Tubulointerstitial nephritis (HP:0001970) | 2.38536005 |
| 86 | Dysmetria (HP:0001310) | 2.36878959 |
| 87 | Anorexia (HP:0002039) | 2.34879736 |
| 88 | Limb dystonia (HP:0002451) | 2.33501349 |
| 89 | Resting tremor (HP:0002322) | 2.32942504 |
| 90 | Atonic seizures (HP:0010819) | 2.27732821 |
| 91 | Maternal diabetes (HP:0009800) | 2.24556890 |
| 92 | EEG with generalized epileptiform discharges (HP:0011198) | 2.21868797 |
| 93 | Postural instability (HP:0002172) | 2.21714838 |
| 94 | Exotropia (HP:0000577) | 2.18526709 |
| 95 | Intention tremor (HP:0002080) | 2.17627876 |
| 96 | Epileptiform EEG discharges (HP:0011182) | 2.17071185 |
| 97 | Hemangiomatosis (HP:0007461) | 2.16903338 |
| 98 | Progressive inability to walk (HP:0002505) | 2.16300432 |
| 99 | Myocardial infarction (HP:0001658) | 2.16026837 |
| 100 | Hemiplegia (HP:0002301) | 2.15148762 |
| 101 | Impaired smooth pursuit (HP:0007772) | 2.11974702 |
| 102 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.11443504 |
| 103 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.11443504 |
| 104 | Lower limb amyotrophy (HP:0007210) | 2.10670216 |
| 105 | Abnormality of macular pigmentation (HP:0008002) | 2.10420494 |
| 106 | Ileus (HP:0002595) | 2.10031328 |
| 107 | Scanning speech (HP:0002168) | 2.09562401 |
| 108 | Hypopigmentation of the fundus (HP:0007894) | 2.08834547 |
| 109 | Specific learning disability (HP:0001328) | 2.08617317 |
| 110 | Hyperventilation (HP:0002883) | 2.08594853 |
| 111 | Incomplete penetrance (HP:0003829) | 2.08042781 |
| 112 | Anencephaly (HP:0002323) | 2.07117796 |
| 113 | Esotropia (HP:0000565) | 2.06781840 |
| 114 | Hypsarrhythmia (HP:0002521) | 2.05012602 |
| 115 | Supernumerary spleens (HP:0009799) | 2.02686027 |
| 116 | Hypoventilation (HP:0002791) | 2.02626802 |
| 117 | Chronic otitis media (HP:0000389) | 2.02507329 |
| 118 | Truncus arteriosus (HP:0001660) | 2.02167356 |
| 119 | Abnormality of oral frenula (HP:0000190) | 2.02159103 |
| 120 | Type II diabetes mellitus (HP:0005978) | 2.01629205 |
| 121 | Oligomenorrhea (HP:0000876) | 2.00474431 |
| 122 | Elfin facies (HP:0004428) | 1.99985704 |
| 123 | Pulmonary embolism (HP:0002204) | 1.99631439 |
| 124 | Scotoma (HP:0000575) | 1.98656933 |
| 125 | Megalencephaly (HP:0001355) | 1.97877039 |
| 126 | Hyperacusis (HP:0010780) | 1.97798923 |
| 127 | Ventricular fibrillation (HP:0001663) | 1.97575191 |
| 128 | True hermaphroditism (HP:0010459) | 1.97294857 |
| 129 | Genetic anticipation (HP:0003743) | 1.95747613 |
| 130 | Hypoplastic left heart (HP:0004383) | 1.95412720 |
| 131 | Abnormality of the labia minora (HP:0012880) | 1.95209072 |
| 132 | Distal upper limb amyotrophy (HP:0007149) | 1.94693154 |
| 133 | Upper limb amyotrophy (HP:0009129) | 1.94693154 |
| 134 | Hypomagnesemia (HP:0002917) | 1.94126814 |
| 135 | Oligodactyly (hands) (HP:0001180) | 1.93920309 |
| 136 | Status epilepticus (HP:0002133) | 1.93276085 |
| 137 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.92844088 |
| 138 | Impaired vibratory sensation (HP:0002495) | 1.92079010 |
| 139 | Bradykinesia (HP:0002067) | 1.92012293 |
| 140 | Pancreatic fibrosis (HP:0100732) | 1.91971613 |
| 141 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91404108 |
| 142 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.90668504 |
| 143 | Absent speech (HP:0001344) | 1.90626258 |
| 144 | Polygenic inheritance (HP:0010982) | 1.88575992 |
| 145 | Hypoalphalipoproteinemia (HP:0003233) | 1.88399544 |
| 146 | Generalized hypotonia (HP:0001290) | 1.88061606 |
| 147 | Dysmetric saccades (HP:0000641) | 1.87943103 |
| 148 | Cortical visual impairment (HP:0100704) | 1.87410290 |
| 149 | Dyskinesia (HP:0100660) | 1.83444827 |
| 150 | Severe visual impairment (HP:0001141) | 1.82637774 |
| 151 | Postural tremor (HP:0002174) | 1.81059395 |
| 152 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.80477390 |
| 153 | Arteriovenous malformation (HP:0100026) | 1.80159183 |
| 154 | Hypoplasia of the brainstem (HP:0002365) | 1.79741136 |
| 155 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.79741136 |
| 156 | Bowel incontinence (HP:0002607) | 1.79535602 |
| 157 | Hyperglycinemia (HP:0002154) | 1.79502704 |
| 158 | Epidermoid cyst (HP:0200040) | 1.79233795 |
| 159 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77101836 |
| 160 | Complete atrioventricular canal defect (HP:0001674) | 1.76998167 |
| 161 | Keratoconus (HP:0000563) | 1.76699876 |
| 162 | Increased corneal curvature (HP:0100692) | 1.76699876 |
| 163 | Inability to walk (HP:0002540) | 1.76666923 |
| 164 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.72311716 |
| 165 | Generalized aminoaciduria (HP:0002909) | 1.72083958 |
| 166 | Toxemia of pregnancy (HP:0100603) | 1.70827349 |
| 167 | Abnormality of the carotid arteries (HP:0005344) | 1.69766932 |
| 168 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.68690007 |
| 169 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.67955331 |
| 170 | Pancreatic cysts (HP:0001737) | 1.67209517 |
| 171 | Myopathic facies (HP:0002058) | 1.66105673 |
| 172 | Abnormality of midbrain morphology (HP:0002418) | 1.65907312 |
| 173 | Molar tooth sign on MRI (HP:0002419) | 1.65907312 |
| 174 | Portal hypertension (HP:0001409) | 1.65504779 |
| 175 | Cone-rod dystrophy (HP:0000548) | 1.59794504 |
| 176 | Hypoplastic heart (HP:0001961) | 1.59358286 |
| 177 | Abnormality of the renal collecting system (HP:0004742) | 1.58982419 |
| 178 | Cavernous hemangioma (HP:0001048) | 1.58361407 |
| 179 | Cutaneous finger syndactyly (HP:0010554) | 1.58316504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.53123688 |
| 2 | MAP3K9 | 4.19476914 |
| 3 | NTRK3 | 3.54143478 |
| 4 | MARK1 | 3.23162711 |
| 5 | WNK3 | 3.20412533 |
| 6 | NTRK2 | 2.79787715 |
| 7 | MINK1 | 2.63053085 |
| 8 | KSR1 | 2.56377749 |
| 9 | SIK3 | 2.47970620 |
| 10 | MAP3K3 | 2.39997597 |
| 11 | MAP2K3 | 2.27648270 |
| 12 | PAK6 | 2.19087081 |
| 13 | ACVR1B | 2.10454007 |
| 14 | KSR2 | 2.06198830 |
| 15 | PRPF4B | 2.04486602 |
| 16 | DAPK2 | 2.02636339 |
| 17 | CDK9 | 2.01470407 |
| 18 | MAP3K4 | 2.01404507 |
| 19 | PRKD3 | 1.95800709 |
| 20 | FGR | 1.91210023 |
| 21 | SIK2 | 1.88051795 |
| 22 | TYRO3 | 1.86854831 |
| 23 | PKN1 | 1.73363571 |
| 24 | UHMK1 | 1.73131795 |
| 25 | CAMKK1 | 1.65615458 |
| 26 | CDK5 | 1.63953424 |
| 27 | JAK3 | 1.63834149 |
| 28 | CCNB1 | 1.55796355 |
| 29 | FRK | 1.53361960 |
| 30 | NEK6 | 1.52800722 |
| 31 | FES | 1.46628151 |
| 32 | MAP2K7 | 1.41169963 |
| 33 | NTRK1 | 1.38746576 |
| 34 | BCR | 1.27495491 |
| 35 | FGFR2 | 1.25343049 |
| 36 | TNIK | 1.24523566 |
| 37 | ADRBK1 | 1.18758788 |
| 38 | TAOK1 | 1.17803510 |
| 39 | CDK18 | 1.16563825 |
| 40 | MAP3K13 | 1.14775136 |
| 41 | DAPK1 | 1.13740314 |
| 42 | CDK19 | 1.12392505 |
| 43 | PNCK | 1.11080592 |
| 44 | EPHB2 | 1.09935831 |
| 45 | MAP2K4 | 1.09889479 |
| 46 | ARAF | 1.08384152 |
| 47 | MAPK13 | 1.08060783 |
| 48 | RIPK4 | 1.07669690 |
| 49 | ICK | 1.06125341 |
| 50 | CDK15 | 1.04307799 |
| 51 | STK38 | 1.03534633 |
| 52 | NEK1 | 1.03179459 |
| 53 | CDK14 | 1.00775951 |
| 54 | RPS6KB2 | 1.00345612 |
| 55 | SGK494 | 0.98759506 |
| 56 | SGK223 | 0.98759506 |
| 57 | CAMK2D | 0.97509136 |
| 58 | CSNK1A1 | 0.95624074 |
| 59 | CAMK2G | 0.93428527 |
| 60 | MAP3K12 | 0.92677528 |
| 61 | MARK2 | 0.92454975 |
| 62 | CDK11A | 0.91648185 |
| 63 | MAPKAPK5 | 0.90696710 |
| 64 | PHKG2 | 0.89601650 |
| 65 | PHKG1 | 0.89601650 |
| 66 | MAP4K2 | 0.89248309 |
| 67 | PRKCG | 0.82948734 |
| 68 | PRKCZ | 0.82051783 |
| 69 | PINK1 | 0.81502745 |
| 70 | ERBB2 | 0.81089380 |
| 71 | ADRBK2 | 0.79722705 |
| 72 | PDGFRA | 0.78890083 |
| 73 | MAPK15 | 0.77876528 |
| 74 | INSRR | 0.77125010 |
| 75 | RET | 0.73661431 |
| 76 | CAMKK2 | 0.72735442 |
| 77 | LMTK2 | 0.72273754 |
| 78 | ERBB4 | 0.71452629 |
| 79 | RIPK1 | 0.71406812 |
| 80 | DYRK1A | 0.69582267 |
| 81 | PRKCH | 0.68433520 |
| 82 | ERBB3 | 0.68357184 |
| 83 | CAMK1 | 0.68262119 |
| 84 | PLK2 | 0.66968427 |
| 85 | TAOK2 | 0.66587173 |
| 86 | MAP3K2 | 0.66194168 |
| 87 | CSNK1G3 | 0.65933525 |
| 88 | STK11 | 0.65032064 |
| 89 | RPS6KB1 | 0.64941567 |
| 90 | DYRK2 | 0.64860757 |
| 91 | RAF1 | 0.64024811 |
| 92 | GRK1 | 0.63795036 |
| 93 | CAMK2A | 0.62301188 |
| 94 | WNK4 | 0.61553323 |
| 95 | JAK2 | 0.61293554 |
| 96 | CSNK1G1 | 0.59818974 |
| 97 | FYN | 0.58354266 |
| 98 | SGK1 | 0.57749748 |
| 99 | PRKCI | 0.57428219 |
| 100 | TRIM28 | 0.55693860 |
| 101 | MAPK10 | 0.52962189 |
| 102 | PAK3 | 0.52588373 |
| 103 | CAMK1D | 0.52542036 |
| 104 | CSNK1A1L | 0.52432097 |
| 105 | CSNK1G2 | 0.51723161 |
| 106 | PDK2 | 0.50256265 |
| 107 | BRSK1 | 0.49323128 |
| 108 | PRKAA1 | 0.48586951 |
| 109 | RPS6KA3 | 0.47992784 |
| 110 | TAOK3 | 0.47343580 |
| 111 | CAMK4 | 0.47302509 |
| 112 | FER | 0.47116527 |
| 113 | TNK2 | 0.46365077 |
| 114 | ALK | 0.46348980 |
| 115 | RPS6KA2 | 0.45285214 |
| 116 | PRKACA | 0.45271411 |
| 117 | PRKCE | 0.45023843 |
| 118 | CAMK2B | 0.44229279 |
| 119 | MKNK2 | 0.44195842 |
| 120 | GRK5 | 0.44012142 |
| 121 | SGK2 | 0.43830325 |
| 122 | DYRK1B | 0.43650961 |
| 123 | PIK3CA | 0.43011459 |
| 124 | PRKCA | 0.42494992 |
| 125 | RPS6KA1 | 0.42063310 |
| 126 | CAMK1G | 0.40531858 |
| 127 | CASK | 0.38853009 |
| 128 | ROCK1 | 0.38763448 |
| 129 | PDPK1 | 0.38494461 |
| 130 | SGK3 | 0.38256695 |
| 131 | CDC42BPA | 0.38247383 |
| 132 | OXSR1 | 0.37616173 |
| 133 | IRAK2 | 0.36783332 |
| 134 | MAP3K7 | 0.36369360 |
| 135 | MAPK9 | 0.36323060 |
| 136 | PRKCB | 0.35197221 |
| 137 | PRKD1 | 0.34431558 |
| 138 | MAP2K1 | 0.34325803 |
| 139 | STK38L | 0.34311786 |
| 140 | PRKACG | 0.31998332 |
| 141 | FGFR1 | 0.31812666 |
| 142 | LATS2 | 0.31531700 |
| 143 | PDK1 | 0.30789667 |
| 144 | MAPK8 | 0.30539558 |
| 145 | DDR2 | 0.30441169 |
| 146 | NUAK1 | 0.29957685 |
| 147 | CSNK1D | 0.29756582 |
| 148 | GSK3B | 0.29058329 |
| 149 | PRKCD | 0.28352579 |
| 150 | PLK4 | 0.27109409 |
| 151 | PRKCQ | 0.27042123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.41991022 |
| 2 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.29353741 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.22451846 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.19357547 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 3.06040368 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.88216556 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71691007 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66286749 |
| 9 | Cocaine addiction_Homo sapiens_hsa05030 | 2.50942372 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.48772618 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48242213 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46929743 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.36775162 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 2.27556156 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.26134019 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21475172 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98273358 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.98154456 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.96670633 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85261097 |
| 21 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.84808683 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.82196646 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.81566462 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76197570 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.74524912 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71332524 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65828853 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.63465257 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62677546 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60872284 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60005880 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54268563 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.52934373 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47213891 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.44027352 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42760196 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.31427594 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28388094 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27300332 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.25212828 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24759294 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23986026 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19470676 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16203991 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16136254 |
| 46 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14923473 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06651764 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06575307 |
| 49 | Glioma_Homo sapiens_hsa05214 | 1.05598754 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02733250 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01035065 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00473719 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00028486 |
| 54 | Alcoholism_Homo sapiens_hsa05034 | 0.98407873 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97915548 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96579421 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96256631 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96241497 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95346336 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.94345984 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93743810 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93680264 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93610668 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92014432 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90112754 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87104201 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86557732 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.84587098 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82933262 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82467718 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80961393 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.78875475 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78344429 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76041684 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75539734 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74599347 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73083925 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71744311 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70879307 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70740694 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68804015 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68550047 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68519976 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67703918 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67637432 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66321806 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65631166 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65248302 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65212788 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63883234 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63144914 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63003034 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61222312 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61201408 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60912499 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60691463 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.59491177 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59304526 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59120774 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57854414 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57541013 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57490003 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56959074 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.54284355 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52612597 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51717530 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50864761 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50747760 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50540311 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50063362 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49447918 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49309514 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49142935 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48409928 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.48339532 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48319626 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47287012 |
| 118 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46894556 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46781631 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45395819 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43032166 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.42892720 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42650986 |
| 124 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42175865 |
| 125 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41386864 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41204695 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.41003399 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40051684 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38779492 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37971167 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37681918 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36801838 |
| 133 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36258076 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35508361 |
| 135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34557847 |
| 136 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33931832 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33854960 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32900206 |
| 139 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31642935 |
| 140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31596086 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29803586 |
| 142 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28812926 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27673068 |
| 144 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27541755 |
| 145 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25144096 |
| 146 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23577040 |

